Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

• Status: Completed
• Trial end date: 2021-01-31
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the efficacy of treatment of striae distensae using the combined modality of fractional laser and poly-L lactic acid (Sculptra).

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Henry Ford Health System
• Collaborators: Galderma; Galderma R&D
• Treatments: Mannitol

Criteria

Inclusion Criteria:

• Subject has bilateral striae alba

• Subject has stable body weight for at least 6 months with Fitzpatrick skin type 1-4

Exclusion Criteria:

• Subject has striae rubra

• Pregnant

• History of adverse effects to phototherapy

• Subject has single sided lesions

• Subject has immunosuppression

• Subject has radiation therapy to the study area

• Subject has topical or oral steroid use or chemotherapy within the last 6 months

• History of keloids or hypertrophic scar